Actuate Therapeutics (ACTU) Cash from Financing Activities (2024 - 2025)
Actuate Therapeutics (ACTU) posted quarterly Cash from Financing Activities of -$29297.0 for Q4 2025, up 73.22% year-over-year from -$16912.9 in Q4 2024, and down 100.17% quarter-over-quarter from $17.1 million in Q3 2025.
Actuate Therapeutics (ACTU) Cash from Financing Activities (2024 - 2025) Analysis & Trends
Actuate Therapeutics (ACTU) has reported Cash from Financing Activities for 2 consecutive years, with -$29297.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash from Financing Activities rose 73.22% year-over-year to -$29297.0; the TTM figure through Dec 2025 stood at $23.7 million (down 13.81% YoY), while the FY2025 annual figure was $23.7 million, down 13.81% from the prior year.
- Cash from Financing Activities retreated to -$29297.0 in Q4 2025 per ACTU's latest filing, from $17.1 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $22.3 million in Q3 2024 and bottomed at -$133477.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -426.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -1.22 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 14.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -6.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 36.24 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -16.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 27.18 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -273.15 Mn |
| 10 | Actuate Therapeutics | 30.08 Mn | 30.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -29,297.00 |
| Dec 31, 2025 | -29,297.00 |
| Sep 30, 2025 | 17.11 Mn |
| Sep 30, 2025 | 17.11 Mn |
| Jun 30, 2025 | 6.78 Mn |
| Jun 30, 2025 | 6.78 Mn |
| Mar 31, 2025 | -133,477.00 |
| Mar 31, 2025 | -133,477.00 |
| Dec 31, 2024 | -109,412.00 |
| Dec 31, 2024 | -109,412.00 |
| Sep 30, 2024 | 22.32 Mn |
| Sep 30, 2024 | 22.32 Mn |
| Jun 30, 2024 | 957,040.00 |
| Jun 30, 2024 | 957,040.00 |
| Mar 31, 2024 | 4.36 Mn |
| Mar 31, 2024 | 4.36 Mn |